Zentalis rises as lead asset extends survival in mid-stage trial for ovarian cancer
Zentalis rises as lead asset extends survival in mid-stage trial for ovarian cancer
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.